Plain-language summary of research published in the Georgian Medical Journal. Written for the general public by the GMJ News editorial team.
Why does one person develop epilepsy and another, with a similar life and similar health, does not? Part of the answer lies in our genes — and a case-control study published in the Georgian Medical Journal investigates one specific genetic suspect in the Georgian population: a variant of the APP gene known as rs463946.
What Is the APP Gene?
APP (amyloid precursor protein) is best known for its central role in Alzheimer’s disease — the amyloid plaques found in Alzheimer’s brains are fragments of the protein this gene produces. But APP also influences how neurons grow, connect, and regulate their electrical excitability. Because epilepsy is fundamentally a disease of excessive electrical excitability in the brain, genes that shape neuronal signalling are natural candidates for epilepsy risk research.
What the Researchers Did
The team compared the frequency of the rs463946 variant in Georgian patients with epilepsy against healthy controls from the same population, testing whether carrying particular versions of this genetic marker was associated with higher epilepsy risk.
Why Population-Specific Genetics Matter
Genetic risk variants often behave differently in different populations — a variant that raises risk in one ethnic group may be neutral in another, because it interacts with the surrounding genetic background. The Georgian population has a distinct genetic history and is dramatically underrepresented in international genetic databases. Studies like this one are how that gap gets closed.
Why It Matters
Epilepsy affects roughly 50 million people worldwide, and in many cases its cause is never identified. Every validated genetic risk marker moves medicine closer to earlier diagnosis, better risk prediction, and eventually treatments targeted at the underlying biology rather than just suppressing seizures. This study adds Georgian evidence to that global effort — and builds domestic capacity for genetic epidemiology research.
Read the Original Research
Original article: Association of the APP rs463946 Polymorphism with Epilepsy Risk: A Case-Control Study from Georgia
Authors: Shorena Vashadze, Maia Beridze, Nana Kvirkvelia, Keso Gorgiladze et al.
Published in: Georgian Medical Journal, Vol. 1 No. 2 (2026) — Health Systems Performance and Quality of Care
DOI: 10.66636/gmj.v1.i2.a110
📄 Read the full article at gmj.ge →
Georgian Medical Journal (GMJ) · ISSN 3088-4322 · gmj.ge · Open Access CC BY 4.0 · Published by the Public Health Institute of Georgia (PHIG). This summary is an independent editorial product of GMJ News; for clinical decisions, consult the original peer-reviewed article and a qualified professional.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
